BACKGROUND: Epidermal growth factor receptor (EGFR) gene copy number has been proposed as predictor of response to epidermal growth factor receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer (NSCLC).METHODS: Cytologic and matched histologic samples from 33 primary non-small cell lung cancers were analyzed by fluorescence in situ hybridization (FISH) for epidermal growth factor receptor gene.RESULTS: FISH was positive in 52% and negative in 35% of the 31 matched evaluable samples. Four of 31 (13%) cases were discordant (K = 0.736; p < 0.001).CONCLUSION: Our data support the feasibility and reliability of epidermal growth factor receptor gene assessment by FISH on cytology.

Is cytology reliable for epidermal growth factor receptor gene evaluation in non-small cell lung cancer? / Bozzetti, C.; Tiseo, M.; Lagrasta, Costanza Anna Maria; Nizzoli, R.; Guazzi, A.; Graiani, G.; Rindi, G.; Ardizzoni, A.. - In: JOURNAL OF THORACIC ONCOLOGY. - ISSN 1556-0864. - 5(2010), pp. 551-553. [10.1097/JTO.0b013e3181ce3b28]

Is cytology reliable for epidermal growth factor receptor gene evaluation in non-small cell lung cancer?

M. Tiseo;LAGRASTA, Costanza Anna Maria;
2010

Abstract

BACKGROUND: Epidermal growth factor receptor (EGFR) gene copy number has been proposed as predictor of response to epidermal growth factor receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer (NSCLC).METHODS: Cytologic and matched histologic samples from 33 primary non-small cell lung cancers were analyzed by fluorescence in situ hybridization (FISH) for epidermal growth factor receptor gene.RESULTS: FISH was positive in 52% and negative in 35% of the 31 matched evaluable samples. Four of 31 (13%) cases were discordant (K = 0.736; p < 0.001).CONCLUSION: Our data support the feasibility and reliability of epidermal growth factor receptor gene assessment by FISH on cytology.
Is cytology reliable for epidermal growth factor receptor gene evaluation in non-small cell lung cancer? / Bozzetti, C.; Tiseo, M.; Lagrasta, Costanza Anna Maria; Nizzoli, R.; Guazzi, A.; Graiani, G.; Rindi, G.; Ardizzoni, A.. - In: JOURNAL OF THORACIC ONCOLOGY. - ISSN 1556-0864. - 5(2010), pp. 551-553. [10.1097/JTO.0b013e3181ce3b28]
File in questo prodotto:
File Dimensione Formato  
Is_Cytology_Reliable_for_Epidermal_Growth_Factor.25.pdf

non disponibili

Tipologia: Documento in Post-print
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 326.1 kB
Formato Adobe PDF
326.1 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
ISCYTOLABS.doc

non disponibili

Tipologia: Abstract
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 22.5 kB
Formato Microsoft Word
22.5 kB Microsoft Word   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11381/2391531
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 7
social impact